Novo Holdings backs European fund; Alnylam sends second obesity drug into clinic

June 4, 2026 10:48 AM EDT News Briefing No­vo Hold­ings backs Eu­ro­pean fund; Al­ny­lam sends sec­ond obe­si­ty drug in­to clin­ic ENDPOINTS Plus news about IMU Bio­sciences, Au­to­bahn and Jade Bio­sciences. 💸 No­vo Hold­ings in­vests in Eu­rope-fo­cused fund: The in­vest­ment man­ag­er of the No­vo Nordisk Foun­da­tion’s for­tunes … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER